Hudson Bay Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-70,469
Closed -$2.89M 1231
2022
Q2
$2.89M Sell
70,469
-18,058
-20% -$877K 0.02% 673
2022
Q1
$5.13M Sell
88,527
-1,341
-1% -$73.4K 0.07% 352
2021
Q4
$5.28M Sell
89,868
-76
-0.1% -$4.61K 0.05% 316
2021
Q3
$5.46M Buy
89,944
+2,512
+3% +$147K 0.07% 298
2021
Q2
$5.25M Sell
87,432
-26,942
-24% -$1.35M 0.06% 322
2021
Q1
$5.39M Sell
114,374
-170,978
-60% -$7.04M 0.07% 257
2020
Q4
$10.7M Sell
285,352
-394,134
-58% -$13M 0.12% 110
2020
Q3
$22.2M Buy
679,486
+34,556
+5% +$1.46M 0.33% 45
2020
Q2
$29.2M Buy
644,930
+119,500
+23% +$6.11M 0.51% 28
2020
Q1
$24M Buy
525,430
+164,035
+45% +$7.42M 0.6% 24
2019
Q4
$15.6M Buy
+361,395
New +$14.7M 0.35% 49

Other funds holding ATEX

Hudson Bay Capital Management's ATEX Position: Q3 2022 in Review

Hudson Bay Capital Management sold out of Anterix (ATEX) in Q3 2022, closing a stake of 70,469 shares — an estimated $2.89M sold.

Hudson Bay Capital Management first reported a position in ATEX in Q4 2019 and held it in 11 quarters. The position peaked at $29.2M in Q2 2020. 100 funds tracked by Wall St. Rank hold ATEX as of Q3 2022.

  • Hudson Bay Capital Management reported no remaining Anterix position as of Q3 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 70,469 Anterix shares in Q3 2022, an estimated $2.89M.
  • Hudson Bay Capital Management first reported a position in Anterix in Q4 2019 and held it in 11 quarters.
  • Hudson Bay Capital Management's Anterix position peaked at $29.2M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Anterix as of Q3 2022.

Based on Hudson Bay Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.